What is EXOZ's proceeds from issuance of warrants?

EXOZ (EXOZ) reported proceeds from issuance of warrants of $2.95K in Q4 2024.

What does proceeds from issuance of warrants mean?

This represents the cash proceeds received from the sale or exercise of warrants, which grant holders the right to purchase company stock at a specified price. It serves as a source of equity financing that can strengthen the company's cash position.

EXOZ EXOZ Proceeds From Issuance Of Warrants

Proceeds From Issuance Of Warrants at other companies

Spectral AI, Inc.MDAI

$2.91M—

Replimune GroupREPL

$0-100%

Sidus Space, Inc.SIDU

$5.63K—

Aura Biosciences, Inc.AURA

$3.54M—

CytomX TherapeuticsCTMX

$5.86M—

ALD

Aldel Financial II Inc.ALDF

$100K—

Other financials

Income statement

See full

Revenue$17.5K—

Operating income-$2.4M-22.4%

Net income-$2.4M-27.7%

EPS (diluted)-$0.28-27.3%

Balance sheet

See full

Cash & equivalents$1.4M-83.0%

Total debt$1.2M-8.8%

Total equity$1.5M-82.8%

Total assets$4.0M-65.1%

Cash flow

See full

Operating cash flow-$1.5M-34.5%

CapEx$57.6K+85.5%

Free cash flow-$1.6M-35.8%

Valuation

See full

Market cap$76.8M-5.6%

Enterprise value$76.57M+1.0%

P/S1,096.1×—

Profitability

See full

Operating margin-14,489.6%—

Net margin-2,909.1%—

FCF margin-10,117.8%—

Returns & leverage

See full

Return on equity-185.8%—

Debt / equity0.8×+0.6×

Current ratio1.3×-5.2×

Where this comes from

Reported directly by EXOZ in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfWarrants.

The official record: EXOZ’s 10-K, filed March 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about EXOZ's proceeds from issuance of warrants.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is EXOZ's proceeds from issuance of warrants?: EXOZ (EXOZ) reported proceeds from issuance of warrants of $2.95K in Q4 2024.
What does proceeds from issuance of warrants mean?: This represents the cash proceeds received from the sale or exercise of warrants, which grant holders the right to purchase company stock at a specified price. It serves as a source of equity financing that can strengthen the company's cash position.